274. 骨形成不全症 Osteogenesis Imperfecta Clinical trials / Disease details

臨床試験数 : 87 / 薬物数 : 103 - (DrugBank : 20) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 76

25 trials found

diseases per page:

Showing 1 to 10 of 25 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000550-21-BG (EUCTR)	01/12/2020	11/09/2020	Study to Assess Long term Safety and Efficacy of Current or Prior Treatment with Denosumabin Childre ...	Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI) MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteo ...	Trade Name: XGEVA Product Name: Denosumab Product Code: AMG 162 INN or Proposed INN: Denosumab Other des ...	Amgen Inc	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	United States;Spain;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Belgium;Poland;Austral ...
2	EUCTR2014-000184-40-PL (EUCTR)	13/10/2020	15/01/2015	Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Denosumabin Children With Osteogenesis I ...	Prospective, Multicenter, Single-arm Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Den ...	Osteogenesis Imperfecta MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteogenes ...	Trade Name: XGEVA Product Name: Denosumab Product Code: AMG 162 INN or Proposed INN: Denosumab Other des ...	Amgen, Inc.	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	United States;Czechia;Spain;Italy;United Kingdom;France;Hungary;Czech Republic;Canada;Poland;Belgium ...
3	EUCTR2018-000550-21-DE (EUCTR)	18/09/2020	20/02/2019	Study to Assess Long term Safety and Efficacy of Current or Prior Treatment with Denosumabin Childre ...	Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI) MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteo ...	Trade Name: XGEVA Product Name: Denosumab Product Code: AMG 162 INN or Proposed INN: Denosumab Other des ...	Amgen Inc	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	United States;Czechia;Spain;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Belgium;Poland ...
4	EUCTR2018-000550-21-CZ (EUCTR)	31/03/2020	14/02/2020	Study to Assess Long term Safety and Efficacy of Current or Prior Treatment with Denosumabin Childre ...	Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI) MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteo ...	Trade Name: XGEVA Product Name: Denosumab Product Code: AMG 162 INN or Proposed INN: Denosumab Other des ...	Amgen Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Czechia;Spain;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Belgium;Poland ...
5	EUCTR2018-000550-21-ES (EUCTR)	01/10/2019	05/07/2019	Study to Assess Long term Safety and Efficacy of Current or Prior Treatment with Denosumabin Childre ...	Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI) MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteo ...	Trade Name: XGEVA Product Name: Denosumab Product Code: AMG 162 INN or Proposed INN: Denosumab Other des ...	Amgen Inc	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	United States;Spain;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Belgium;Poland;Austral ...
6	EUCTR2018-000550-21-IT (EUCTR)	21/06/2019	15/06/2021	Study to Assess Long term Safety and Efficacy of Current or PriorTreatment with Denosumabin Children ...	Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI) MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteo ...	Trade Name: XGEVA Product Name: Denosumab Product Code: [AMG 162] INN or Proposed INN: Denosumab Other d ...	AMGEN INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Czechia;Spain;Austria;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Belgiu ...
7	EUCTR2018-000550-21-GB (EUCTR)	07/03/2019	17/06/2019	Study to Assess Long term Safety and Efficacy of Current or Prior Treatment with Denosumabin Childre ...	Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI) MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteo ...	Trade Name: XGEVA Product Name: Denosumab Product Code: AMG 162 INN or Proposed INN: Denosumab Other des ...	Amgen Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Spain;United Kingdom;Italy;France;Czech Republic;Hungary;Canada;Belgium;Poland;Austral ...
8	NCT03638128 (ClinicalTrials.gov)	July 26, 2018	21/6/2018	Multicenter, Single-arm Open-label Extension Study to Assess Long-term Safety and Efficacy of Curren ...	Multicenter, Single-arm Open-label Extension Study to Assess Long-term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI)	Drug: Denosumab;Other: No treatment;Drug: Alternative osteoporosis medications	Amgen	NULL	Active, not recruiting	5 Years	20 Years	All	75	Phase 3	United States;Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Spain;United King ...
9	EUCTR2018-000550-21-HU (EUCTR)	06/07/2018	10/05/2018	Study to Assess Long term Safety and Efficacy of Current or Prior Treatment with Denosumabin Childre ...	Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Curren ...	Osteogenesis Imperfecta (OI) MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteo ...	Trade Name: XGEVA Product Name: Denosumab Product Code: AMG 162 INN or Proposed INN: Denosumab Other des ...	Amgen Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Spain;United Kingdom;Italy;France;Hungary;Czech Republic;Canada;Belgium;Poland;Austral ...
10	NCT02352753 (ClinicalTrials.gov)	June 24, 2015	28/1/2015	Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumabin Childre ...	To Evaluate the Effect of Denosumabin Lumbar Spine Bone Mineral Density (BMD) Z-score at 12 Months, ...	Osteogenesis Imperfecta	Drug: Denosumab	Amgen	NULL	Active, not recruiting	2 Years	17 Years	All	153	Phase 3	United States;Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Spain;Un ...

First Previous1 2 3Next Last